Helix BioPharma Corp. announced demise of chairman of the board of directors Prof. Dr. S Slawomir Majewski. Dr. Majewski has been on the voard since 2012 and has led the company as its interim chief executive since September 2021.

Majewski had been head of the department of dermatology and venereology, Warsaw Medical University, Poland, since 1998 and was previously Deputy Rector for science and international relations at the Medical University of Warsaw and coordinator of the Polish Center of Preclinical Studies and Technology. Majewski also previously served as member of the scientific advisory board at the Polish Ministry of Health.